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COMPUTATIONAL MODELLING: MOONLIGHTING ON THE NEUROSCIENCE 
AND MEDICINE 
Parichehr Hassanzadeh 
Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran 
Computational modelling has emerged as a powerful tool to study the behaviour of complex systems. Computer simulation may 
lead to a better understanding of the function of biological systems and the pathophysiological mechanisms underlying various 
diseases. In neuroscience, modelling techniques have provided knowledge about the electrical properties of neurons, activity 
of ion channels, synaptic function, information processing, and signalling pathways. Using simulations and analysis in net-
work models has resulted in greater understanding of the behaviour of neural networks and dynamics of synaptic connectivity. 
Moreover, the correlation between the neurobiological mechanisms and a cluster of physiological, cognitive, and behavioural 
phenomena may be explored by the computational modelling of the neuronal systems. In this context, a significant progress has 
been made in understanding of the neural network architectures including those with a high degree of connectivity between 
the units, information processing, performance of complex cognitive tasks, integration of brain signals, as well as the dynamic 
mechanisms and computations implemented in the brain for making goal-directed choices. Computational models are able to 
explore the interactions between the brain areas which are involved in predictive processes and high-level skills. In this review, 
the significance of computational modelling in the study of neural networks, decision-making procedure, nerve growth factor 
signalling, and endocannabinoid system along with its medical applications have been highlighted. Biomed Rev 2013; 24: 25-31
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INTRODUCTION
In recent years, the development of computational models 
has given the opportunity to study a wide range of complex 
systems in silico. The modelling approaches may also be used 
to make useful predictions. For example, important predictions 
from the computational models of the basal ganglia have been 
obtained which exhibit practical implications for neurologi-
cal disorders such as Parkinson’s disease (1). Meanwhile, the 
model selection and validation as well as the parameter esti-
mation are necessary for improving model performance (2). 
In neuroscience, biophysical models have made a significant 
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contribution to the understanding of the electrical properties 
of neurons. These models have also been used to investigate 
the signalling pathways underlying synaptic plasticity (3) lead-
ing to a deeper understanding of memory storage in neurons 
and information processing. From a historical point of view, 
Hodgkin and Huxley were the first who created the biophysical 
models. They developed equations in order to describe how the 
action potentials are propagated throughout the axons via the 
voltage-gated ion channels and employed the voltage-sensitive 
fast-acting sodium and the inward-rectifying potassium cur-
rents to predict the qualitative features and timing of the action 
potential (4). Although Hodgkin and Huxley’s model provided 
an efficient explanation for the contribution of the aforemen-
tioned ion channels to the neuronal activity, other important 
features of the neural networks such as shunting and adaptation 
remained unpredictable. In fact, the complexity of neuronal 
dynamics and cellular signalling networks necessitates the de-
velopment of descriptive, mechanistic, or interpretive models. 
The first multicompartmental neural modelling was designed 
by Wilfrid Rall using cable theory (2). Afterwards, model-
ling of complex cognitive processes was performed in order 
to explore the habitual and rule-governed features of human 
performance (5,6). Altogether, simulation experiments are 
designed to solve the complex problems and determine how 
a system may be affected by various conditions. 
COMPUTATIONAL MODELS fOR NEURAL NETwORkS 
Neurons are the complex and specialized cells which consist 
of differentiated domains for receiving and transmitting a flow 
of information. In human nervous system, several billion of 
neurons form intricate networks through which high-speed 
signals pass in a complex and dynamically changing pattern. 
Development of computational models has led to a better 
understanding of the complex interconnections between the 
neurons. Furthermore, computational modelling has provided 
knowledge about the neuronal development, axonal guidance, 
sensory processing, synaptic plasticity and memory, as well 
as the adaptive and discriminative properties of the brain in 
certain contexts (7). Although the organizational principles of 
the brain may be understood by other fields of science such 
as biology or psychology, the consolidation of these findings 
is performed through the unified descriptive models and da-
tabases as well as the quantitative modelling of brain activity 
(8). In the neural network model, the behaviour of individual 
neurons and dynamics of neural circuitry may be evaluated. 
In order to develop computational models to study the neural 
information processing, a special attention should be paid to 
the electric circuit analogies as well as the electro-dynamical 
variables including the current, resistance, and voltage. In 
addition, the designer of a neural network usually needs to 
simulate the synaptic transmission in the nervous system (9). 
In a basic multiple-input computational model, each neuron 
is considered as a processor which has a dynamic connection 
with other neurons. The soma and dendrites receive the in-
puts and integrate the signals of pre-synaptic nerve terminals 
(10). In recent years, the interaction of different currents 
with geometric properties of neurons and the computational 
functions of dendrites have been under intense investigation 
(3,6). Moreover, several models have been designed in order 
to track the biochemical pathways at very small scales such 
as the spines or synaptic clefts (11). In transsynaptic neuronal 
changes due to the neurodegenerative processes (12), compu-
tational intelligence techniques including the neural network 
or evolutionary algorithms have been employed in medical 
imaging that may provide an efficient and reliable detection 
of structural damage in neurons. In this respect, computational 
modelling of cell replacement may be a promising approach 
for the treatment of neurological disorders (13). Computational 
models may also clarify the synapse function in response 
to the external stimulus at different time scales. Based on a 
stereochemical model, it has been shown that acetylcholine 
receptor-based synapse works at time scale of microseconds 
(14,15). The maintenance or change of the memory in multiple 
time scales is one of the major problems in neuroscience. In 
this context, significant effort has been made to develop the 
biologically relevant models (16). Several models have been 
designed to explore the interactions between the episodic and 
working memories in the hippocampus and prefrontal cortex, 
respectively (17,18). 
APPLICATION Of COMPUTATIONAL MODELS IN DECISION-
MAkING AND PRObLEM-SOLvING TECHNIqUES
In goal-directed choices, an action is usually chosen among 
others which are associated with costs and reward outcomes. In 
decision-making procedure, a series of computations are usu-
ally implemented in the brain (19). Combination of modelling 
and psychometrics may also be used for acquiring knowledge 
about the algorithms that are used by the brain to compare the 
action values (20). Human functional magnetic resonance im-
aging (fMRI) studies have provided evidence about the nature 
of brain function in a complex decision-making paradigm 
or sophisticated problem-solving (21). In this sense, a novel 
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decision-making paradigm has been used to dissociate the basic 
decision-making computations including the stimulus values 
and prediction errors. Based on the findings, activation of the 
medial orbitofrontal cortex is correlated with stimulus values, 
while, activation of the ventral striatum is correlated with 
prediction errors (22). In making dietary decisions, models 
and algorithms have shown the critical role of the orbitofrontal 
cortex in self-control (23). Using a mathematical framework, 
it has been demonstrated that the anterior areas of prefrontal 
cortex are involved in making more complex decisions (24). 
An attempt for modeling the human cognitive procedures 
has been recently made through the simulated processes like 
acquired rule-based systems or manipulation of visual repre-
sentations in decision-making (25). Computational modeling 
of cognitive functions has revealed that information from 
multiple sensory modalities are integrated in the frontal and 
parietal lobes of the brain (26,27).
COMPUTATIONAL MODELLING Of NERvE GROwTH fACTOR 
SIGNALLING
Nerve growth factor (NGF), the prototypic member of the 
neurotrophin family of growth factors, which was discovered 
by the Nobel Laureate, Rita Levi-Montalcini, plays a pivotal 
role in neuronal cell growth and differentiation in both periph-
eral and central nervous systems in health and disease (28,29). 
Furthermore, NGF is implicated in (i) the mechanism of action 
of a wide range of psychotropic agents (30-34), and (ii) the 
therapeutic effect in neuropsychiatric and cardiometabolic 
diseases (29,35-37). Since the mechanisms underlying the 
formation of complex neural networks have not been fully 
understood, the methods of statistical mechanics have been 
recently applied to extract predictions for cellular signalling 
networks. In this respect, NGF-induced neuronal differentia-
tion has been modelled (38). In another modelling approach, 
the actions of NGF and epidermal growth factor (EGF) in rat 
pheochromocytoma cells have been investigated. Based on 
the findings, NGF and EGF stimulate extracellular regulated 
kinase phosphorylation with distinct dynamic profiles (39). 
These data give the opportunity to predict the cellular response 
to growth factors.
APPLICATION Of COMPUTATIONAL MODELS fOR THE STUDy 
Of THE ENDOCANNAbINOID SySTEM 
The functionality of a neural network depends on the acquisi-
tion of morphological and functional polarization that begins 
with axonal specification and elongation. The endocannabi-
noid system (eCBs) which is implicated in the mechanism 
of action of psychotropic agents and regulation of hypotha-
lamic-pituitary-adrenal axis activity (30-33,40,41), exerts a 
regulatory role on neuronal differentiation, dendritogenesis, 
and synaptogenesis (42). This ubiquitous signalling system 
mediates the inhibition of electric potentials (43), blocking of 
synapse stabilization (44), and short-term synaptic weaken-
ing (45). In fact, the eCBs is a neural network which plays a 
key role in the brain development processes and modulates 
brain functions (46), involving the cannabinoid CB1 recep-
tors. The neuromodulatory action of eCBs at network level 
is not yet fully understood. Using computational modelling, 
it has been shown that CB1 receptors modulate the electrical 
activity in cortical neural networks (47). Modelling of the 
hippocampal neurons has revealed that CB1 receptors play 
a critical role in the maturation of dendrites and assembly of 
axon initial segment (48). Neural network models have also 
demonstrated the modulatory effects of the eCBs on rapid 
eye movement (REM)-sleep. The activation of eCB-CB1 
signalling system results in the attenuation of brain activation 
during the REM-sleep (49). Moreover, neural network models 
have demonstrated the modulatory effects of CB1 receptors 
on gamma-aminobutyric acid (GABA) transmission in the 
activated brain regions during REM-sleep (50).
MEDICAL APPLICATIONS Of COMPUTATIONAL MODELLING
Designing of drug delivery systems 
In recent years, application of nanoparticles composed of 
discrete molecules and chemicals for targeted drug delivery 
has attracted a growing interest. The physical characteristics 
of nanoparticles enable them to deliver their contents directly 
to the disease site (51). In this context, computational models 
in which the fate of nanoparticles are simulated, have been 
developed to study the interactions of nanoparticles with the 
biological environments (52). This may result in the develop-
ment of more precise drug delivery systems.
Predicting the adverse effects of drugs 
In the early stages of drug discovery, computational models 
may be used to predict the potential side effects (53). This 
approach, other than the patient safety, may save time in drug 
approval process.
Tissue repair
A wide variety of diseases with multiple symptoms or dis-
abilities have created demands towards the development of 
regeneration strategies or tissue replacement. Meanwhile, 
the limited efficiency and slow development of the currently 
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available biomaterials limit their utility for regenerative appli-
cations. The modelling toolkits have been designed to predict 
the best composition for biomaterials leading to the optimized 
conditions for tissue repair (54). 
Eye surgery 
Computational modelling may be used to refine the technique 
of laser eye surgery for a better vision. In this sense, biome-
chanical models of human cornea have been developed to 
simulate the laser surgery. These models may be used in the 
virtual course for ophthalmologists-in-training (55).
Tuberculosis
Six months of treatment with several antibiotics may result in 
noncompliance in patients with tuberculosis. An experimental/
computational approach has been recently used for modelling 
of the disease and patient’s immune response that may lead to 
the prediction of treatment outcome and patient adherence (56).
Cardiometabolic diseases 
Computational models have been used to improve the design 
of implanted devices including the coronary artery stents, 
artificial heart valves, the mechanics of blood vessel growth, 
blood flow, and heart valves (57). The models are also promis-
ing for further study of obesity therapy (58). Of note, a recent 
project designated multi-scale immune system simulator for 
the onset of type 2 diabetes (MISSION-T2D) aims to develop 
an integrated and patient-specific model, clustering multiple 
data for the simulation and prediction of the onset and pro-
gression of this cardiometabolic disease (59). Computational 
models have also provided decision-making tools which are 
based on the detailed analysis of the specific characteristics of 
patients leading to a more effective treatment (60). 
Imaging 
Development of the imaging techniques such as fMRI, PET, 
magnetoencephalography, and diffuse optical tomography 
has resulted in the remarkable advances in neuroscience. 
Simultaneous application of these techniques may provide 
more detailed information about the brain structure and 
its functional dynamics. Computational models in which 
several imaging modalities are combined have provided the 
opportunity to monitor the brain function during anaesthesia 
or sleep (61,62). Similar models may be used for a better 
understanding of the dynamics of brain function during the 
neurological disorders. 
Biosensor technology
Biosensor is an analytical device which is made up of a spe-
cific biological element that recognizes a specific analyte, and 
a transducer which translates a biorecognition event into an 
electrical signal (63). Biosensors are widely used for clinical 
diagnostics and drug analysis (64-66). In order to optimize 
the configuration of a biosensor, computer-aided modelling 
may introduce various efficient designs. Thus, computational 
modelling of biosensors with perforated membranes has at-
tracted an influential interest (67,68). 
CONCLUSION
Computational models have provided a unique opportunity to 
develop novel hypothesis and solutions towards the challeng-
ing scientific problems. In this context, computational model-
ling for the neural system has resulted in a better understanding 
of the underlying physiological and biochemical events that 
mediate the key neuronal properties. Using the neural network 
computing and hybrid neural techniques, the complex ana-
lytical problems may be solved and the demands of modern 
neuroscience research be met. Noteworthy, the development 
of appropriate methods, algorithms, and software in the fields 
of mathematics, physics, chemistry, and biomedicine is critical 
for providing sufficient computational power. Such an in silico 
power may hopefully be transmitted to in vivo applications 
in biomedicine.
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